A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Headache; Migraine
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 Planned End Date changed from 1 Sep 2016 to 1 Aug 2016.
- 16 Jun 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Aug 2016.